
Michael B. Pallay
Examiner (ID: 335, Phone: (571)270-3473 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 879 |
| Issued Applications | 427 |
| Pending Applications | 115 |
| Abandoned Applications | 374 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20023050
[patent_doc_number] => 20250161272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => Microsphere-Based Injectable Celecoxib Formulation
[patent_app_type] => utility
[patent_app_number] => 19/034843
[patent_app_country] => US
[patent_app_date] => 2025-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19034843
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/034843 | Microsphere-based injectable celecoxib formulation | Jan 22, 2025 | Issued |
Array
(
[id] => 20023050
[patent_doc_number] => 20250161272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => Microsphere-Based Injectable Celecoxib Formulation
[patent_app_type] => utility
[patent_app_number] => 19/034843
[patent_app_country] => US
[patent_app_date] => 2025-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19034843
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/034843 | Microsphere-based injectable celecoxib formulation | Jan 22, 2025 | Issued |
Array
(
[id] => 19768233
[patent_doc_number] => 20250049659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => ORAL COMPOSITIONS AND METHODS OF REDUCING ORAL MALODOR
[patent_app_type] => utility
[patent_app_number] => 18/930284
[patent_app_country] => US
[patent_app_date] => 2024-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18930284
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/930284 | ORAL COMPOSITIONS AND METHODS OF REDUCING ORAL MALODOR | Oct 28, 2024 | Pending |
Array
(
[id] => 19510408
[patent_doc_number] => 20240342094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 18/740160
[patent_app_country] => US
[patent_app_date] => 2024-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18740160
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/740160 | COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS | Jun 10, 2024 | Pending |
Array
(
[id] => 19691126
[patent_doc_number] => 20250009671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => COATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/737814
[patent_app_country] => US
[patent_app_date] => 2024-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18737814
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/737814 | COATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME | Jun 6, 2024 | Pending |
Array
(
[id] => 19417259
[patent_doc_number] => 20240293382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE
[patent_app_type] => utility
[patent_app_number] => 18/662545
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662545
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662545 | MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE | May 12, 2024 | Pending |
Array
(
[id] => 19417259
[patent_doc_number] => 20240293382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE
[patent_app_type] => utility
[patent_app_number] => 18/662545
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662545
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662545 | MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE | May 12, 2024 | Pending |
Array
(
[id] => 19417259
[patent_doc_number] => 20240293382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE
[patent_app_type] => utility
[patent_app_number] => 18/662545
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662545
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662545 | MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE | May 12, 2024 | Pending |
Array
(
[id] => 19613030
[patent_doc_number] => 20240398710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/644608
[patent_app_country] => US
[patent_app_date] => 2024-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18644608
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/644608 | MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION | Apr 23, 2024 | Pending |
Array
(
[id] => 19613030
[patent_doc_number] => 20240398710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/644608
[patent_app_country] => US
[patent_app_date] => 2024-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18644608
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/644608 | MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION | Apr 23, 2024 | Pending |
Array
(
[id] => 19359220
[patent_doc_number] => 20240261254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM
[patent_app_type] => utility
[patent_app_number] => 18/641369
[patent_app_country] => US
[patent_app_date] => 2024-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641369
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/641369 | DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM | Apr 19, 2024 | Pending |
Array
(
[id] => 19359220
[patent_doc_number] => 20240261254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM
[patent_app_type] => utility
[patent_app_number] => 18/641369
[patent_app_country] => US
[patent_app_date] => 2024-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641369
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/641369 | DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM | Apr 19, 2024 | Pending |
Array
(
[id] => 19331225
[patent_doc_number] => 20240245655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING SEPSIS
[patent_app_type] => utility
[patent_app_number] => 18/627293
[patent_app_country] => US
[patent_app_date] => 2024-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18627293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/627293 | METHODS AND COMPOSITIONS FOR TREATING SEPSIS | Apr 3, 2024 | Abandoned |
Array
(
[id] => 19297828
[patent_doc_number] => 20240226394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => MULTI-LAYERED POLYMER FILM FOR SUSTAINED RELEASE OF AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/609954
[patent_app_country] => US
[patent_app_date] => 2024-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/609954 | Multi-layered polymer film for sustained release of agents | Mar 18, 2024 | Issued |
Array
(
[id] => 19359315
[patent_doc_number] => 20240261349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Pharmaceutical Complex for Radioprotection, Preparation Method, and Applications thereof
[patent_app_type] => utility
[patent_app_number] => 18/606877
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606877
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606877 | Pharmaceutical Complex for Radioprotection, Preparation Method, and Applications thereof | Mar 14, 2024 | Abandoned |
Array
(
[id] => 19613349
[patent_doc_number] => 20240399029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => ADIPOSE TISSUE MATRICES
[patent_app_type] => utility
[patent_app_number] => 18/602676
[patent_app_country] => US
[patent_app_date] => 2024-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602676
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/602676 | ADIPOSE TISSUE MATRICES | Mar 11, 2024 | Abandoned |
Array
(
[id] => 19477271
[patent_doc_number] => 20240325313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI
[patent_app_type] => utility
[patent_app_number] => 18/592784
[patent_app_country] => US
[patent_app_date] => 2024-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18592784
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/592784 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI | Feb 29, 2024 | Pending |
Array
(
[id] => 19232060
[patent_doc_number] => 20240189251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine
[patent_app_type] => utility
[patent_app_number] => 18/581460
[patent_app_country] => US
[patent_app_date] => 2024-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581460
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/581460 | Treatment of vomiting and nausea with minimum dose of olanzapine | Feb 19, 2024 | Issued |
Array
(
[id] => 19156061
[patent_doc_number] => 20240148768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => Method of Preventing and Treating COVID-19 Infection
[patent_app_type] => utility
[patent_app_number] => 18/411935
[patent_app_country] => US
[patent_app_date] => 2024-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411935
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/411935 | Method of Preventing and Treating COVID-19 Infection | Jan 11, 2024 | Abandoned |
Array
(
[id] => 19156061
[patent_doc_number] => 20240148768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => Method of Preventing and Treating COVID-19 Infection
[patent_app_type] => utility
[patent_app_number] => 18/411935
[patent_app_country] => US
[patent_app_date] => 2024-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411935
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/411935 | Method of Preventing and Treating COVID-19 Infection | Jan 11, 2024 | Abandoned |